Bio2 Medical touted data yesterday from the pivotal study of its Angel catheter in 163 critically ill patients with high risk of acute pulmonary embolism and contraindications to anticoagulation. The study met its safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism, according to the company. The trial evaluated patients […]
Bio2 Medical raises $1.5m, looking for $6.5m more
Bio2 Medical raised $1.5 million in a new round of debt and option financing, according to an SEC filing posted this week. Money in the round came from 1 unnamed investor, with the date of the sale noted as March 18, according to the filing. The company has not yet stated how it plans to spend […]
FDA nod for Angel catheter triggers $3m tranche for Bio2 Medical
The 510(k) clearance Bio2 Medical won from the FDA in July for its Angel catheter triggered a 2nd, $3 million tranche from Oxford Finance last week, the company said yesterday. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to […]
Bio2 Medical wins FDA clearance for embolism-snaring Angel catheter
BiO2 Medical said today it won FDA 510(k) clearance for its Angel Catheter designed for pulmonary embolism protection by trapping clinically significant pulmonary emboli. The Golden, Colo.-based company said the clearance includes a 1st ever prophylactic indication to protect critically ill patients at high risk for pulmonary embolism and are contraindicated for anticoagulation. “We are excited […]
BiO2 Medical drums up $8m from Oxford Finance
Oxford Finance said yesterday it closed an $8 million secured term loan with Angel catheter maker BiO2 Medical, with funds slated to support FDA clearance and an anticipated commercial launch of the catheter in mid-2016. If you need personal loans for people with bad credit online services, visit www.unsecuredloans4u.co.uk for more information. The Angel catheter […]
BiO2 Medical drums up $9m Series D for Angel catheter
BiO2 Medical said yesterday that it raised a $9 million Series D round for its Angel catheter, after concluding its pivotal clinical trial a year ahead of schedule. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San […]
BiO2 Med miracle: Angel cath pivotal trial ends 1 year early
BiO2 Medical said today the pivotal clinical trial of its Angel catheter hit its target of 150 evaluable patients and has concluded a solid year earlier than anticipated. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San […]
BiO2 Medical raises $4m of $10m round
BiO2 Medical, developer of the Angel Catheter prophylactic pulmonary embolism protection device, said it raised $4 million, according to a regulatory filing. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. BiO2 Medical […]
